AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2019
Jan 10, 2019
34931_dirs_2019-01-10_2fd3ac20-d404-43b1-be5c-d62e8a57cf7e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CALADRIUS BIOSCIENCES, INC. (CLBS)
CIK: 0000320017
Period of Report: 2019-01-08
Reporting Person: KLOSK STEVEN M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-01-08 | Common Stock | A | 8747 | — | Acquired | 17812 | Direct |
Footnotes
F1: Represents 8,747 shares underlying restricted stock granted under the 2018 Equity Incentive Compensation Plan which were awarded on January 8, 2018 and which vested on January 8, 2019.